{"id":"https://openalex.org/W2501269018","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7609","title":"Sorafenib treatment efficacy and KRAS biomarker status in the Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial.","display_name":"Sorafenib treatment efficacy and KRAS biomarker status in the Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2501269018","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7609","mag":"2501269018"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.7609","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7609","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.7609","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008593691","display_name":"Roy S. Herbst","orcid":"https://orcid.org/0000-0003-2535-5847","observed_orcids":["https://orcid.org/0000-0003-2535-5847"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. S. Herbst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077579849","display_name":"George R. Blumenschein","orcid":"https://orcid.org/0000-0002-9606-8194","observed_orcids":["https://orcid.org/0000-0002-9606-8194"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. R. Blumenschein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078483387","display_name":"E. S. Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. S. Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046143450","display_name":"J. Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057281549","display_name":"Anne S. Tsao","orcid":"https://orcid.org/0000-0003-0505-6639","observed_orcids":["https://orcid.org/0000-0003-0505-6639"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. S. Tsao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014225996","display_name":"Christine M. Alden","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. M. Alden","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020305963","display_name":"S. Liu","orcid":"https://orcid.org/0009-0000-3388-6280","observed_orcids":["https://orcid.org/0009-0000-3388-6280"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100609224","display_name":"David J. Stewart","orcid":"https://orcid.org/0000-0002-0184-7946","observed_orcids":["https://orcid.org/0000-0002-0184-7946"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. J. Stewart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028085268","display_name":"Ignacio Ivan Wistuba","orcid":"https://orcid.org/0000-0003-3365-6340","observed_orcids":["https://orcid.org/0000-0003-3365-6340"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. I. Wistuba","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111144617","display_name":"Waun Ki Hong","orcid":"https://orcid.org/0009-0008-9329-5544","observed_orcids":["https://orcid.org/0009-0008-9329-5544"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. K. Hong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"7609","last_page":"7609"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9679999947547913},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.8180000185966492},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.8759999871253967},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9229999780654907},{"id":"https://openalex.org/keywords/biomarker-guided-therapy","display_name":"biomarker-guided therapy","score":0.6800000071525574},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.9070000052452087},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.7200000286102295},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.7319999933242798},{"id":"https://openalex.org/keywords/vandetanib","display_name":"vandetanib","score":0.824999988079071},{"id":"https://openalex.org/keywords/bexarotene","display_name":"bexarotene","score":0.9179999828338623},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.44999998807907104},{"id":"https://openalex.org/keywords/biomarker-testing","display_name":"biomarker testing","score":0.30300000309944153},{"id":"https://openalex.org/keywords/hand-foot-syndrome","display_name":"hand-foot syndrome","score":0.6000000238418579},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.43799999356269836},{"id":"https://openalex.org/keywords/advanced-non-small-cell-lung-cancer","display_name":"advanced non-small cell lung cancer","score":0.4480000138282776},{"id":"https://openalex.org/keywords/egfr-copy-number","display_name":"EGFR copy number","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9174779653549194},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.7820059061050415},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7209194898605347},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.719762921333313},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6789182424545288},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.6547593474388123},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.631362795829773},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.5590940117835999},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.44746431708335876},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.41559842228889465},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4001542925834656},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32067590951919556},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3042072057723999},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.14124774932861328},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.07008305191993713}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.7609","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7609","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.7609","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2122327814","https://openalex.org/W2599991410","https://openalex.org/W2500954855","https://openalex.org/W1945781200","https://openalex.org/W2964630855","https://openalex.org/W2560339164","https://openalex.org/W2604478339","https://openalex.org/W1969411102","https://openalex.org/W2161381592","https://openalex.org/W2131006629"],"abstract_inverted_index":{"7609":[0],"Background:":[1],"BATTLE":[2],"is":[3],"a":[4,30,74,248,300],"phase":[5,54],"II":[6],"study":[7],"to":[8,13,47,66,71,80,135,167,175,257,282,330],"prospectively":[9],"use":[10],"biomarkers":[11,78],"(BM)":[12],"guide":[14],"treatment":[15,353],"selection":[16],"in":[17,73,84,192,233,255,260,319],"patients":[18],"(PTS)":[19],"with":[20,43,59,228,236,244,264,266,270,296,322,354],"advanced":[21],"non-small":[22],"cell":[23,186],"lung":[24],"cancer":[25],"(NSCLC).":[26],"This":[27,340],"report":[28],"details":[29],"subset":[31],"analysis":[32],"of":[33,40,122,194,201,247],"the":[34,136,245,286],"8-week":[35],"disease":[36],"control":[37],"rate":[38],"(DCR)":[39],"PTS":[41,58,111,133,172,197,226,243,262,269,284,295,320,344],"treated":[42,227,263,321],"sorafenib":[44],"(S)":[45],"relative":[46],"their":[48],"BM":[49,118],"status.":[50],"Methods:":[51],"In":[52,242,268],"this":[53],"II,":[55],"multi-arm":[56],"study,":[57],"pretreated":[60],"NSCLC,":[61],"ECOG":[62,188],"PS":[63],"0-2,":[64],"consented":[65],"fresh":[67],"core":[68],"needle":[69],"biopsies":[70],"test,":[72],"research":[75],"lab,":[76],"11":[77],"related":[79],"4":[81,123],"molecular":[82],"pathways":[83],"NSCLC":[85],"(EGFR,":[86],"KRAS,":[87],"and":[88,95,101,107,117,129,159,218],"BRAF":[89],"gene":[90],"mutation":[91,287],"[PCR-based":[92],"sequencing],":[93],"EGFR":[94,272,297,334,360],"Cyclin":[96],"D1":[97],"copy":[98,337],"number":[99,338,362],"[FISH],":[100],"6":[102],"proteins":[103],"via":[104],"IHC":[105],"[VEGF/R":[106],"RXR":[108],"receptors/Cyclin":[109],"D1]).":[110],"were":[112,155,173,207,240],"randomized,":[113],"based":[114],"on":[115],"eligibility":[116],"grouping,":[119],"into":[120],"1":[121],"treatments":[124],"(erlotinib":[125],"[E],":[126],"sorafenib,":[127],"vandetinab":[128],"erlotinib":[130],"plus":[131],"bexarotene).":[132],"randomized":[134,174],"S":[137,140,229,323],"arm":[138],"received":[139],"400":[141],"mg":[142],"orally":[143],"twice":[144],"daily":[145],"until":[146],"tumor":[147],"progression":[148],"or":[149,336,375,379],"an":[150,271],"unacceptable":[151],"toxicity.":[152],"Tumor":[153],"evaluations":[154],"performed":[156],"at":[157],"baseline":[158],"every":[160],"8":[161],"weeks.":[162],"The":[163,203],"primary":[164],"objective":[165],"was":[166,190,230,252,275,317],"assess":[168],"DCR.":[169],"Results:":[170],"105":[171],"receive":[176],"S:":[177],"82%":[178],"Caucasian,":[179],"51%":[180],"male,":[181],"68%":[182],"adenocarcinoma,":[183],"13%":[184],"squamous":[185],"carcinoma,":[187],"status":[189],"0-1":[191],"89%":[193],"PTS.":[195],"31":[196],"had":[198,299,325,333],"dose":[199],"reduction/discontinuation":[200],"S.":[202],"most":[204],"common":[205],"reasons":[206],"hand-foot":[208],"syndrome":[209],"(n":[210,214,220],"=":[211,215,221,290,293,313],"6),":[212],"hemoptysis":[213],"5),":[216],"fatigue,":[217],"rash":[219],"2":[222,392],"each).":[223],"DCR":[224,251,274,316],"for":[225],"58%":[231],"(57":[232],"98":[234],"pts":[235],"outcome).":[237],"No":[238],"responses":[239],"observed.":[241],"presence":[246],"KRAS":[249,326,347],"mutation,":[250,273],"61%":[253],"(11/18),":[254],"contrast":[256],"31%":[258],"(4/13)":[259],"KRAS-mutated":[261],"regimens":[265],"E.":[267],"significantly":[276],"lower":[277,301],"(23%,":[278],"3/13)":[279],"when":[280,328],"compared":[281,329],"those":[283,304,331,357],"without":[285],"(64%,":[288],"n":[289],"43/67)":[291],"(p":[292,312],"0.012).":[294],"high-polysomy":[298],"DC":[302],"than":[303],"who":[305,324,332,345,358],"did":[306],"not":[307],"(27%,":[308],"3/11;":[309],"62%,":[310],"42/68)":[311],"0.048).":[314],"Conclusions:":[315],"improved":[318],"mutations":[327,335,348],"gain.":[339],"result":[341],"suggests":[342],"that":[343],"have":[346,359],"may":[349,364],"derive":[350],"benefit":[351],"from":[352],"S,":[355],"while":[356],"mutation/copy":[361],"gain":[363],"do":[365],"worse.":[366],"Supported":[367],"by":[368],"DoD":[369],"grant":[370],"W81XWH-6-1-0303.":[371],"Author":[372],"Disclosure":[373],"Employment":[374],"Leadership":[376],"Position":[377],"Consultant":[378],"Advisory":[380],"Role":[381],"Stock":[382],"Ownership":[383],"Honoraria":[384],"Research":[385],"Funding":[386],"Expert":[387],"Testimony":[388],"Other":[389],"Remuneration":[390],"Align":[391],"Action,":[393],"Inc,":[394],"AstraZeneca,":[395,412],"Bayer,":[396,413],"Bridger":[397],"Capital,":[398],"LLC,":[399],"Gascon":[400],"Associates,":[401],"Genentech,":[402,414],"Liquidia":[403],"Technologies,":[404],"Medacorp,":[405],"Nectar":[406],"Therapeutics,":[407],"OSI,":[408],"Trinity":[409],"Partners,":[410],"LLC":[411],"OSI":[415]},"counts_by_year":[{"year":2022,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":11}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-08-23T00:00:00"}